ABSI
Absci Corp
NASDAQ · Healthcare · Biotechnology · US
$8.54
+3.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 54.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.95x
- Price / sales
- 938.87x
- Price / cash flow
- -13.56x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 812.38x
- EV / EBITDA
- -11.54x
- EV / EBIT
- -9.66x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026